Trenton, NJ, January 21, 2017 — New Jersey’s rare disease community will gather to celebrate Rare Disease Day 2017 on Monday, February 27 from 9:00 a.m. to 12:00 p.m. at the New Jersey Business and Industry Association (NJBIA) at 10 West Lafayette Street in Trenton.
The half-day event will be sponsored by BioNJ, the HealthCare Institute of New Jersey (HINJ), New Jersey Rare Disease Alliance and NORD.
The morning will begin at 9:00 a.m. with coffee, pastries and networking, followed by speakers from the rare disease community, including patients, patient advocates, legislators, biomedical healthcare professionals and life sciences community leaders. Continue reading
PhRMA: First-of-Its-Kind Study Shows Growing Share of Medicine List Prices Going to Rebates and Supply Chain
Washington, DC, January 20, 2017 — Robust competition in the private marketplace is resulting in increasingly higher rebates and discounts on medicine prices, according to a new study by the Berkeley Research Group (BRG).
The Pharmaceutical Research and Manufacturers of America (PhRMA) commissioned the study.
The study is among the first to examine the share of prescription medicine spending retained by biopharmaceutical companies, generic manufacturers, pharmacy benefit managers (PBMs), health plans and other stakeholders in the supply chain. Continue reading
Bethesda, MD, January 20, 2017 — Dylan Scott reports on STAT that Dr. Francis Collins is being held over as the director of the National Institutes of Health by the Trump administration, his office announced Thursday afternoon.
Dr. Collins had been prepared to step down from the post on Friday, after Trump’s inauguration, and return to his lab at the NIH Bethesda campus. However, with Thursday’s news, he will remain as director for the time being.
It is not yet known whether Trump will permanently reappoint Collins to be his NIH director for his full term. Collin’s office directed all further questions to the Trump transition. Continue reading
Denville, NJ, January 20, 2017 — Anajalee Khamlani reports on NJBIZ that, after completely rebranding and disassociating from the national Alzheimer’s Association, the 1-year-old Alzheimer’s New Jersey is standing on fairly stable ground.
There were some hiccups, such as donors being confused by the Greater New Jersey Alzheimer’s Association chapter and Alzheimer’s New Jersey’s new brand, as well as similar schedules for events and walks, but overall, things went smoothly, said CEO and President Kenneth Zaentz.
“We are definitely on track for what we want to accomplish,” he said. Continue reading
Rowan University/Rutgers-Camden Board of Governors Publish Report on Economic Impact on Camden and the State
Camden, NJ, January 20, 2017 — The Rowan University/Rutgers-Camden Board of Governors (RURCBOG) has published an economic and fiscal impact report.
The 16-page report is attached to this email. It also may be accessed online by clicking here.
The RURCBOG was created by the New Jersey Medical and Health Sciences Education Restructuring Act, which took effect on August 22, 2012.
The Board’s mission reflects an extension of Camden’s significant “eds and meds” presence and is expected to leverage the educational and research assets to support growth in the region’s health care capacity.
Davos, Switzerland, January 19, 2017 — Reuters reports that two decades after they were spurred into action to tackle AIDS in Africa, global drugmakers said yesterday that they would invest an initial $50 million over three years to fight cancer and other non-communicable diseases in poor countries.
Twenty-two companies — including Pfizer, Merck, Novartis, Roche, Sanofi and GlaxoSmithKline — will contribute funds and expertise to the project, which is backed by the World Bank. Continue reading
New Brunswick, NJ, January 19, 2017 — Andrew Sheldon reports on NJBIZ that nine of the state’s top colleges and universities have signed a memorandum of agreement to formally establish the New Jersey Big Data Alliance (NJBDA).
The aim of the NJBDA is to bring together the diverse advanced cyberinfrastructure resources and talent housed at the state’s universities, colleges and NJEDge.Net, according to a news release.
Margaret Brennan-Tonetta, associate vice president for economic development at Rutgers and a founder of the NJBDA, said the agreement was a step toward making the Garden State a leader in an emerging field. Continue reading
Gov. Christie Signs Executive Order Declaring Opioid Drug Abuse a Public Health Crisis; Creates Drug Abuse Task Force
Trenton, NJ, January 18, 2017 — Intensifying his Administration’s commitment in the fight against substance abuse, Governor Chris Christie yesterday signed Executive Order 219 declaring the opioid epidemic a public health crisis in New Jersey.
The action requires the marshalling of all appropriate resources to combat its harmful effects on state citizens.
“We must take aggressive action to get this insidious crisis under control so I am calling together all resources of state government in order to save lives,” said Governor Christie. Continue reading
Washington, DC, January 18, 2017 — The Washington Post today reports that a new analysis that at least 18 million people could lose health insurance in the first year if Congress repeals the Affordable Care Act without replacing it intensified the battle this week over the landmark health-care law as President-elect Donald Trump and Republicans try to figure out how to dismantle it.
Democrats seized on the report, issued Tuesday by the nonpartisan Congressional Budget Office, to discredit Republican efforts to repeal Obamacare and rally Americans who are insured under the program. Continue reading
New Brunswick, NJ, January 18, 2017 — The HealthCare Institute of New Jersey (HINJ) is pleased to co-sponsor a Rutgers-Industry Cancer Symposium that will be presented on Tuesday, January 24 from 4:00 to 6:00 p.m. in Auditorium A and B at the Rutgers Cancer Institute of New Jersey at 195 Little Albany Street, New Brunswick.
This series is designed to foster collaboration and networking between Rutgers faculty and strategic industry partners.
At the January 24 symposium, Rutgers researchers will present an update on clinical investigations.
In addition, Incyte Corporation will present an update on drugs in its pipeline.
Registration is not required. For the event flyer, click here.